HK:2256 Stock Latest News
Company AnnouncementsAbbisko Cayman Limited Completes Name Change to Abbisko Medicine3h ago2256
Company AnnouncementsAbbisko’s Achondroplasia Drug Wins EMA Orphan Status, Advancing Global Push1w ago2256
Company AnnouncementsAbbisko Therapeutics Posts Encouraging Phase II Data for Pediatric Achondroplasia Drug1M ago2256
Company AnnouncementsAbbisko Shareholders Back Name Change to Abbisko Medicine Co., Ltd.1M ago2256
Company AnnouncementsAbbisko Therapeutics Begins First-in-Human Trial of Novel Pan-KRAS Cancer Drug ABSK2112M ago2256Company AnnouncementsAbbisko Seeks Shareholder Approval to Rebrand as Abbisko Medicine Co., Ltd.2M ago2256
Company AnnouncementsAbbisko Cayman Advances Oncology Pipeline as Lead Drug Pimicotinib Launches in China2M ago2256
Company AnnouncementsAbbisko Proposes Rebrand to Abbisko Medicine Co., Ltd. Without Impact on Trading2M ago2256
Company AnnouncementsAbbisko Wins China IND Nod for Pan-KRAS Cancer Drug ABSK2112M ago2256
Company AnnouncementsAbbisko Sets August Board Meeting to Approve Interim Results and Weigh Dividend3M ago2256- Company AnnouncementsAbbisko Wins FDA IND Clearance for Pan-KRAS Cancer Drug ABSK2113M ago2256
Company AnnouncementsAbbisko and AstraZeneca Launch Joint Trial of Novel NSCLC Combination4M ago2256Company AnnouncementsAbbisko Showcases Promising Phase II FGFR2-Targeted Combo Data in Advanced Gastric Cancer4M ago2256
Company AnnouncementsAbbisko Deepens Lilly Partnership in Multitarget Drug R&D Deal Worth Up to US$1.9 Billion4M ago2256
Company AnnouncementsAbbisko Showcases Advanced Modeling for Liver Cancer Drug ABSK-011 at European Meeting5M ago2256
Company AnnouncementsAbbisko Shareholders Back All AGM Resolutions, Bolstering Capital and Governance Flexibility5M ago2256
Company AnnouncementsAbbisko Cayman Raises HK$517 Million Through Share Placing to Fund Drug Development6M ago2256- Company AnnouncementsAbbisko Moves to Modernise Governance With Digital-Ready Articles Update6M ago2256
Company AnnouncementsAbbisko Cayman Sets 2026 AGM to Approve Results, Board Changes and 20% Share Issue Mandate6M ago2256Company AnnouncementsAbbisko Showcases Broad Oncology Pipeline with Pan‑KRAS Data at 2026 AACR6M ago2256
Company AnnouncementsAbbisko Cayman to Raise HK$517 Million via Discounted Share Placing for R&D Push6M ago2256